Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In re HIV Antitrust Litigation
Case Number:
3:19-cv-02573
See also:
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Arnold & Porter
- Baron & Budd
- Berry Silberberg
- Boies Schiller
- Crowell & Moring
- Dillingham & Murphy
- Duane Morris
- Faegre Drinker
- Glancy Prongay
- Goodwin Procter
- Hagens Berman
- Hangley Aronchick
- Hausfeld LLP
- Hilliard & Shadowen
- Holland & Knight
- Kanner & Whiteley
- Kellogg Hansen
- Kenny Nachwalter
- Kessler Topaz
- Kirkland & Ellis
- Law Offices of Francis O. Scarpulla
- Lockridge Grindal
- Milberg Coleman
- Miller Shah LLP
- Morrison Foerster
- NastLaw
- Nixon Peabody
- Nussbaum Law Group
- Pritzker Levine
- Proskauer Rose
- Radice Law Firm
- Rivero Mestre
- Robins Kaplan
- Spector Roseman
- Sperling & Slater
- Whatley Kallas
- White & Case
- Wilson Sonsini
- Zelle LLP
Companies
- Aetna Inc.
- Akros Pharma Inc.
- Albertsons Cos. Inc.
- Amneal Pharmaceuticals Inc.
- Blue Cross Blue Shield Association
- BlueCross BlueShield of South Carolina
- Bristol-Myers Squibb Co.
- Centene Corp.
- Cipla Ltd.
- CVS Health Corp.
- Florida Blue
- Fraternal Order of Police
- Gilead Sciences Inc.
- Health Care Service Corp.
- Humana Inc.
- Japan Tobacco
- Johnson & Johnson
- LifeWallet
- Mylan NV
- Rite Aid Corp.
- Service Employees International Union
- Teva Pharmaceutical Industries Ltd.
- The Kroger Co.
- Zydus Pharmaceuticals Inc.
Government Agencies
Sectors & Industries:
-
November 04, 2022
HIV Drug Buyers Win Cert. In Gilead, Janssen Antitrust Suit
A California federal judge granted class certification to end-payor plaintiffs and direct-purchaser plaintiffs in a suit accusing Gilead and Janssen of artificially inflating HIV drug prices by illegally staving off competition from cheaper generics, according to an order unsealed this week.
-
October 31, 2022
Direct HIV Med Buyers Seek OK Of $10.8M Bristol-Myers Deal
A putative class of direct HIV medication buyers asked a California federal judge to give final approval to a $10.8 million deal that would end claims that Bristol-Myers Squibb engaged in anti-competitive conduct to block generics competition and keep the medication's prices artificially high.
-
April 07, 2022
Gilead Says Aetna Must Litigate Its HIV Drug Suit In Fed Court
Gilead urged a California federal judge Thursday to reject Aetna's bid to send to state court its second lawsuit accusing Gilead and others of illegally driving up HIV drug prices by blocking generic versions, saying Aetna already dropped a similar suit and shouldn't be allowed to pursue this litigation "tactic."
-
March 29, 2022
Gilead Can't Force Aetna HIV Suit On Its Terms
A California federal judge refused Tuesday to let Gilead forcibly revive an Aetna lawsuit, which the insurer voluntarily dismissed, in order to avoid a state court fight alongside the array of federal antitrust lawsuits accusing the drugmaker and others of driving up HIV drug prices by illegally staving off cheaper generic versions.
-
March 16, 2022
BCBS Stays In Gilead HIV Suit As More Than An Intermediary
The Blue Cross Blue Shield Association has sufficiently demonstrated it belongs, for now, among end-payors accusing Gilead Sciences Inc. and Janssen Pharmaceuticals of driving up HIV drug prices by illegally staving off cheaper generic versions, according to a California federal judge.
-
March 08, 2022
UnitedHealth's HIV Drug Suit Against Teva, Gilead Trimmed
A California federal court on Tuesday trimmed several state law claims while keeping others intact in United Healthcare's suit alleging it overpaid for HIV drugs because Teva and Gilead delayed cheaper generic versions.
-
March 03, 2022
Gilead, Teva Look To Trim United Health's HIV Generics Suit
Teva and Gilead urged a California federal judge Thursday to trim some state claims from United Healthcare's suit alleging the pair overcharged for HIV drugs by delaying cheaper generic versions, saying that consumer protection laws in some states named in the complaint do not extend to corporations or insurance companies.
-
January 14, 2022
Judge Limits Tolling On Retailer Claims In HIV Generics Suit
A California federal judge has trimmed antitrust claims that retailers including Walgreens and CVS filed against Teva over alleged overcharges for HIV drugs, saying any claims stretching back more than four years from their lawsuits are time-barred.
-
January 05, 2022
Teva Urges Judge To Limit Walgreens, CVS Antitrust Claims
Teva Pharmaceuticals urged a California federal judge Wednesday to curb antitrust claims brought by Walgreens, CVS and other retailers alleging that the pharmaceutical giant conspired with rival Gilead to keep generic versions of blockbuster HIV treatments off the market, arguing that some of the retailers' claims are time-barred.
-
November 05, 2021
Bristol-Myers Inks $10M Deal To End Drug Antitrust Claims
Bristol-Myers Squibb has reached a $10 million settlement to escape claims that it conspired with rivals to keep a blockbuster HIV treatment off the market, and both sides are hoping that a California federal judge will preliminarily bless the deal.